Orexo AB (Sweden) Analysis
| ORX Stock | SEK 12.28 1.92 18.53% |
Orexo AB is undervalued with Real Value of 11.33 and Hype Value of 10.36. The main objective of Orexo AB stock analysis is to determine its intrinsic value, which is an estimate of what Orexo AB is worth, separate from its market price. There are two main types of Orexo AB's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Orexo AB's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Orexo AB's stock to identify patterns and trends that may indicate its future price movements.
The Orexo AB stock is traded in Sweden on Stockholm Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Sweden. Orexo AB is usually not traded on NationalDay, International Workers ' Day, St . John 's Day, All Saints ' Day, Christmas Eve, Christmas Day, Boxing Day, New Year 's Day, Epiphany, Good Friday, Easter Sunday, Easter Monday. Orexo Stock trading window is adjusted to Europe/Stockholm timezone.
Orexo |
Orexo Stock Analysis Notes
About 17.0% of the company outstanding shares are owned by corporate insiders. The book value of Orexo AB was now reported as 5.64. The company recorded a loss per share of 6.28. Orexo AB had not issued any dividends in recent years. The entity had 1904:1903 split on the 31st of May 2011. Orexo AB , a specialty pharmaceutical company, develops products based on proprietary drug delivery technology. Orexo AB was founded in 1995 and is headquartered in Uppsala, Sweden. Orexo AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 130 people. To find out more about Orexo AB contact Nikolaj Sorensen at 46 1 87 80 88 00 or learn more at https://www.orexo.com.Orexo AB Investment Alerts
| Orexo AB generated a negative expected return over the last 90 days | |
| Orexo AB has high historical volatility and very poor performance | |
| The company has kr519 Million in debt which may indicate that it relies heavily on debt financing | |
| The company reported the revenue of 624.3 M. Net Loss for the year was (183.9 M) with profit before overhead, payroll, taxes, and interest of 521.7 M. | |
| Orexo AB has accumulated about 697 M in cash with (156.6 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 19.64, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 17.0% of the company outstanding shares are owned by corporate insiders |
Orexo Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 612.75 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Orexo AB's market, we take the total number of its shares issued and multiply it by Orexo AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Orexo Profitablity
Orexo AB's profitability indicators refer to fundamental financial ratios that showcase Orexo AB's ability to generate income relative to its revenue or operating costs. If, let's say, Orexo AB is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Orexo AB's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Orexo AB's profitability requires more research than a typical breakdown of Orexo AB's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.28) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.29) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.29. Technical Drivers
As of the 26th of November, Orexo AB holds the Variance of 8.04, risk adjusted performance of (0.17), and Coefficient Of Variation of (429.92). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Orexo AB, as well as the relationship between them.Orexo AB Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Orexo AB middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Orexo AB. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Orexo AB Outstanding Bonds
Orexo AB issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Orexo AB uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Orexo bonds can be classified according to their maturity, which is the date when Orexo AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
Orexo AB Predictive Daily Indicators
Orexo AB intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Orexo AB stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 19206.9 | |||
| Daily Balance Of Power | 0.7273 | |||
| Rate Of Daily Change | 1.19 | |||
| Day Median Price | 11.82 | |||
| Day Typical Price | 11.97 | |||
| Price Action Indicator | 1.42 | |||
| Period Momentum Indicator | 1.92 |
Orexo AB Forecast Models
Orexo AB's time-series forecasting models are one of many Orexo AB's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Orexo AB's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Orexo Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Orexo AB prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Orexo shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Orexo AB. By using and applying Orexo Stock analysis, traders can create a robust methodology for identifying Orexo entry and exit points for their positions.
Orexo AB , a specialty pharmaceutical company, develops products based on proprietary drug delivery technology. Orexo AB was founded in 1995 and is headquartered in Uppsala, Sweden. Orexo AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 130 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Orexo AB to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Balance Of Power Now
Balance Of PowerCheck stock momentum by analyzing Balance Of Power indicator and other technical ratios |
| All Next | Launch Module |
Additional Tools for Orexo Stock Analysis
When running Orexo AB's price analysis, check to measure Orexo AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orexo AB is operating at the current time. Most of Orexo AB's value examination focuses on studying past and present price action to predict the probability of Orexo AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orexo AB's price. Additionally, you may evaluate how the addition of Orexo AB to your portfolios can decrease your overall portfolio volatility.